Politics and Legality
Rolling Stone
2021-11-11
U.S. Gov’t Funds First Therapeutic Psilocybin Research in 50 Years
The National Institutes of Health is helping Johns Hopkins study whether the psychoactive chemial psilocybin could help people quit smoking.
Share:
Related News
DEA Calls For Increased Production Of Some Psychedelics For Research, As Marijuana Quotas Level Out Ahead Of Scheduling Decision
The Drug Enforcement Administration (DEA) has released new quotas for the production of Schedule I and Schedule II controlled substances for research purposes—calling for an increase in the manufacturing of the psychedelics ibogaine, psilocybin and psilocyn, while continuing to maintain stable quotas for other substances such as marijuana, THC and MDMA. As DEA prepares to […]
Read More
Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming “No” Vote
Following last week’s negative headlines, we review how Lykos Therapeutics unsuccessfully sought to reassure the committee, how its apparent policy of minimal engagement might have backfired…
Read More
Bipartisan Congressional Lawmakers Tell VA To Prepare Plan For MDMA-Assisted Therapy As FDA Considers Approving The Psychedelic
Bipartisan congressional lawmakers are asking the U.S. Department of Veterans Affairs (VA) to produce a plan to begin providing MDMA-assisted therapy for veterans as soon as the psychedelic is approved by the Food and Drug Administration (FDA). In a letter sent to VA Under Secretary Shereef Elnahal on Tuesday, Reps. Morgan McGarvey (D-KY), Morgan Luttrell […]
Read More
Australian Federal Government Funds Trial of MDMA-Assisted Therapy for Individuals Affected by Northern River Floods
Researchers at Southern Cross University (SCU) in Australia will trial the use of MDMA-assisted therapy (MDMA-AT) in patients suffering from natural disaster-related PTSD. The government has assigned…
Read More